These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25248754)

  • 81. Diagnostic questions in hypertrophic cardiomyopathy: what is the significance of late enhancement on cardiac magnetic resonance?
    Almeida AG
    Rev Port Cardiol; 2014 May; 33(5):269-71. PubMed ID: 24909444
    [No Abstract]   [Full Text] [Related]  

  • 82. Cardiomyopathies: Myocardial fibrosis assessed by CMR to predict events in HCM.
    Ajmone Marsan N; Bax JJ
    Nat Rev Cardiol; 2010 Nov; 7(11):604-6. PubMed ID: 20975656
    [No Abstract]   [Full Text] [Related]  

  • 83. Myocardial mechanics in noncontiguous HCM.
    Agarwal A; Khandheria BK; Paterick TE; Bloomgarden D; Loberg R; Bush M; Tajik AJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1216-8. PubMed ID: 24229776
    [No Abstract]   [Full Text] [Related]  

  • 84. Contrast enhancement for the myocardium.
    Higgins CB; Saeed M; Wendland M
    Magn Reson Med; 1991 Dec; 22(2):347-53; discussion 364-5. PubMed ID: 1812369
    [No Abstract]   [Full Text] [Related]  

  • 85. Letter by Ellims et al regarding article, "myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy".
    Ellims AH; Iles LM; Taylor AJ
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):e1. PubMed ID: 23512783
    [No Abstract]   [Full Text] [Related]  

  • 86. Letter regarding Morsbach et al. "Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy".
    Ma H; Wang Y; Wang Y; Shi L; Zhang J; Wen Z; Chen L; Wang Z; Shi Y; Sun C; Pan Y; Liu J; Xie H; Yang J
    Int J Cardiol; 2018 Apr; 256():35. PubMed ID: 29395363
    [No Abstract]   [Full Text] [Related]  

  • 87. Response to letter regarding article, "myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy".
    Dass S; Suttie JJ; Piechnik SK; Ferreira VM; Holloway CJ; Banerjee R; Mahmod M; Cochlin L; Karamitsos TD; Robson MD; Watkins H; Neubauer S
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):e2. PubMed ID: 23512784
    [No Abstract]   [Full Text] [Related]  

  • 88. Further Refining Risk in Hypertrophic Cardiomyopathy With Late Gadolinium Enhancement by CMR.
    Kramer CM; Neubauer S
    J Am Coll Cardiol; 2018 Aug; 72(8):871-873. PubMed ID: 30115225
    [No Abstract]   [Full Text] [Related]  

  • 89. The emerging role of cardiovascular magnetic resonance in refining the diagnosis of hypertrophic cardiomyopathy.
    Moon JC; McKenna WJ
    Nat Clin Pract Cardiovasc Med; 2009 Mar; 6(3):166-7. PubMed ID: 19139744
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Assessing risk for ventricular tachyarrhythmias and sudden cardiac death: is there a role for cardiac MRI?
    Wu KC
    Circ Cardiovasc Imaging; 2012 Jan; 5(1):2-5. PubMed ID: 22253332
    [No Abstract]   [Full Text] [Related]  

  • 91. Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death.
    Finocchiaro G; Sheikh N; Leone O; Westaby J; Mazzarotto F; Pantazis A; Ferrantini C; Sacconi L; Papadakis M; Sharma S; Sheppard MN; Olivotto I
    Europace; 2021 Jul; 23(7):985-995. PubMed ID: 33447843
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The missing spade: apical hypertrophic cardiomyopathy investigation.
    Alpendurada F; Prasad SK
    Int J Cardiovasc Imaging; 2008 Oct; 24(7):687-9. PubMed ID: 18595001
    [No Abstract]   [Full Text] [Related]  

  • 93. Late gadolinium enhancement in cardiomyopathy.
    Alpendurada F; Pennell DJ
    Int J Cardiovasc Imaging; 2008 Aug; 24(6):613-5. PubMed ID: 18481194
    [No Abstract]   [Full Text] [Related]  

  • 94. Progression of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy: Another Piece of the Puzzle.
    Petretta A; Cuocolo A; Petretta M
    Am J Cardiol; 2024 Feb; 212():137-138. PubMed ID: 38101463
    [No Abstract]   [Full Text] [Related]  

  • 95. Detection of apical hypertrophic cardiomyopathy by magnetic resonance imaging.
    Casolo GC; Trotta F; Rostagno C; Poggesi L; Galanti G; Masotti G; Bartolozzi C; Dabizzi RP
    Am Heart J; 1989 Feb; 117(2):468-72. PubMed ID: 2916416
    [No Abstract]   [Full Text] [Related]  

  • 96. Advanced imaging for risk stratification of sudden death in hypertrophic cardiomyopathy.
    Ramchand J; Fava AM; Chetrit M; Desai MY
    Heart; 2020 Jul; 106(14):1111-1112. PubMed ID: 32451363
    [No Abstract]   [Full Text] [Related]  

  • 97. [Research progress of risk stratification by cardiac magnetic resonance in patients with hypertrophic cardiomyopathy].
    Qiao JH; Zhao PJ; Lu JY; Huang L; Xia LM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Apr; 50(4):327-331. PubMed ID: 35399027
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Late gadolinium enhancement and prognosis of hypertrophic cardiomyopathy.
    Sakuma H
    Circ J; 2014; 78(4):832-4. PubMed ID: 24614511
    [No Abstract]   [Full Text] [Related]  

  • 99. Hypertrophic cardiomyopathy: refining the lens of cardiac magnetic resonance to evaluate late gadolinium enhancement.
    Bluemke DA; Yang E
    J Am Coll Cardiol; 2012 Sep; 60(10):930-1. PubMed ID: 22935465
    [No Abstract]   [Full Text] [Related]  

  • 100. Exuberant pattern of late gadolinium enhancement in hypertrophic cardiomyopathy.
    Fernandes E; Camargo GC; Derenne ME; Rothstein T; Gottlieb I
    Arq Bras Cardiol; 2013 Oct; 101(4):e80-2. PubMed ID: 24217436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.